tiprankstipranks
Trending News
More News >
ERYTECH PHARMA (GB:0QSS)
:0QSS
UK Market

ERYTECH PHARMA (0QSS) Technical Analysis

Compare
0 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
ERYTECH PHARMA’s (0QSS) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting ERYTECH PHARMA is a Sell.
ERYTECH PHARMA’s (0QSS) 20-Day exponential moving average is 0.40, while ERYTECH PHARMA’s (0QSS) share price is €0.29, making it a Sell.
ERYTECH PHARMA’s (0QSS) 50-Day exponential moving average is 0.72, while ERYTECH PHARMA’s (0QSS) share price is €0.29, making it a Sell.

ERYTECH PHARMA (0QSS) Pivot Points

May 22, 2025, 07:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.25
0.26
0.27
0.28
0.30
0.31
0.32
Fibonacci
0.26
0.27
0.27
0.28
0.29
0.30
0.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ERYTECH PHARMA (0QSS) Moving Averages

May 22, 2025, 07:43 AM
Period
Simple
Exponential
MA5
0.29Buy
0.30Sell
MA10
0.33Sell
0.33Sell
MA20
0.37Sell
0.40Sell
MA50
0.74Sell
0.72Sell
MA100
1.28Sell
1.08Sell
MA200
1.52Sell
1.43Sell
ERYTECH PHARMA’s (0QSS) 10-Day exponential moving average is 0.33, while ERYTECH PHARMA’s (0QSS) share price is €0.29, making it a Sell.
ERYTECH PHARMA’s (0QSS) 100-Day exponential moving average is 1.08, while ERYTECH PHARMA’s (0QSS) share price is €0.29, making it a Sell.
ERYTECH PHARMA’s (0QSS) stock price is €0.29 and ERYTECH PHARMA’s (0QSS) 50-day simple moving average is 0.74, creating a Sell signal.
ERYTECH PHARMA’s (0QSS) stock price is €0.29 and ERYTECH PHARMA’s (0QSS) 100-day simple moving average is 1.28, creating a Sell signal.
ERYTECH PHARMA’s (0QSS) stock price is €0.29 and ERYTECH PHARMA’s (0QSS) 200-day simple moving average is 1.52, creating a Sell signal.

ERYTECH PHARMA (0QSS) Technical Indicators

May 22, 2025, 07:43 AM
Name
Value
Implied Action
RSI (14)
31.88
Neutral
STOCH (9,6)
14.58
Buy
STOCHRSI (14)
9.65
Buy
MACD (12,26)
-0.13
Sell
ADX (14)
32.34
Neutral
Williams %R
-86.49
Buy
CCI (14)
-83.53
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
41.59
Neutral
ROC
-30.95
Sell
ERYTECH PHARMA’s (0QSS) Relative Strength Index (RSI) is 31.88, creating a Neutral signal.
ERYTECH PHARMA’s (0QSS) Trend Strength Indicator (ADX) is 32.34, creating a Neutral signal.
ERYTECH PHARMA’s (0QSS) Commodity Channel Index (CCI) is -83.53, creating a Neutral signal.
ERYTECH PHARMA’s (0QSS) Price Rate of Change (ROC) is -30.95, creating a Sell signal.

FAQ

Is 0QSS a Buy, Hold, or Sell?
Based on 0QSS’s technical indicators, 0QSS is a Sell.
    What is 0QSS’s RSI (14)?
    0QSS’s RSI (14) is 31.88, which suggests 0QSS is a Neutral.
      What is 0QSS’s MACD?
      0QSS’s MACD is -0.13, which suggests 0QSS is a Sell.
        What is 0QSS’s 5-day moving average?
        0QSS’s 5-day moving average is 0.29, which suggests 0QSS is a Buy.
          What is 0QSS’s 20-day moving average?
          0QSS 20-day moving average is 0.37, which suggests 0QSS is a Sell.
            What is 0QSS’s 50-day moving average?
            0QSS’s 50-day moving average is 0.74, which suggests 0QSS is a Sell.
              What is 0QSS’s 200-day moving average?
              0QSS’s 200-day moving average is 1.52, which suggests 0QSS is a Sell.
                What is 0QSS’s Williams % R (14)?
                0QSS’s Williams % R (14) is -86.49, which suggests 0QSS is a Buy.
                  What is 0QSS’s CCI (14)?
                  0QSS’s CCI (14) is -83.53, which suggests 0QSS is a Neutral.
                    What is the share price of ERYTECH PHARMA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis